Cargando…

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora

Liver cirrhosis is a form of liver fibrosis resulting from chronic hepatitis caused by various liver diseases, such as viral hepatitis, alcoholic liver damage, nonalcoholic steatohepatitis, autoimmune liver disease, and by parasitic diseases such as schistosomiasis. Liver fibrosis is the common path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xianzhi, Wang, Lifu, Tan, Siwei, Chen, Zebin, Wu, Bin, Wu, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924518/ https://www.ncbi.nlm.nih.gov/pubmed/35308208 http://dx.doi.org/10.3389/fphar.2022.814871

Ejemplares similares

Rhubarb polysaccharide and berberine co-assembled nanoparticles ameliorate ulcerative colitis by regulating the intestinal flora
por: Feng, Yifan, et al.
Publicado: (2023)

Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders
por: Liu, Min, et al.
Publicado: (2023)

The intervention effect of Amygdalus mongolica oil on the metabolomics and intestinal flora in pulmonary fibrosis
por: Li, Qian, et al.
Publicado: (2022)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
por: Cai, Yajie, et al.
Publicado: (2023)

The impact of herbal medicine in regulating intestinal flora on female reproductive disorders
por: Liu, Min, et al.
Publicado: (2022)

Scientific connotation of the compatibility of traditional Chinese medicine from the perspective of the intestinal flora
por: Gao, Yuan, et al.
Publicado: (2023)

Effect of Berberine Hydrochloride on the Diversity of Intestinal Flora in Parkinson's Disease Patients
por: Li, Jiaojiao, et al.
Publicado: (2022)

Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis
por: Yi, Jiazhi, et al.
Publicado: (2021)

Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology
por: Liu, Yingying, et al.
Publicado: (2022)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology
por: Liu, Yingying, et al.
Publicado: (2023)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation
por: Ren, Gang, et al.
Publicado: (2020)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

Polysaccharide, the Active Component of Dendrobium officinale, Ameliorates Metabolic Hypertension in Rats via Regulating Intestinal Flora-SCFAs-Vascular Axis
por: Li, Bo, et al.
Publicado: (2022)

A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats
por: Zhang, Shichang, et al.
Publicado: (2022)

Effects of Berberine on the Gastrointestinal Microbiota
por: Zhang, Lichao, et al.
Publicado: (2021)

Editorial: The Effect of Herbal Medicine on Intestinal Flora and the Potential Molecular Mechanism
por: Liu, Wei, et al.
Publicado: (2023)

Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats
por: Gong, Jing, et al.
Publicado: (2017)

Cornus officinalis prior and post-processing: Regulatory effects on intestinal flora of diabetic nephropathy rats
por: Ju, Cheng-Guo, et al.
Publicado: (2022)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis
por: Rafiei, Hossein, et al.
Publicado: (2023)

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

Chinese Medicine Formula Siwu-Yin Inhibits Esophageal Precancerous Lesions by Improving Intestinal Flora and Macrophage Polarization
por: Shi, Hui-Juan, et al.
Publicado: (2022)

Tongxinluo May Alleviate Inflammation and Improve the Stability of Atherosclerotic Plaques by Changing the Intestinal Flora
por: Qi, Yan, et al.
Publicado: (2022)

Berberine Facilitates Extinction and Prevents the Return of Fear
por: Huang, Shihao, et al.
Publicado: (2022)

Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice
por: Cao, Hui, et al.
Publicado: (2020)

Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
por: Ai, Xiaopeng, et al.
Publicado: (2021)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022)

Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Ye, Yu, et al.
Publicado: (2021)

Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice
por: Wan, Si-Zhe, et al.
Publicado: (2019)

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
por: Wang, Fa-Da, et al.
Publicado: (2022)

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
por: Li, Le, et al.
Publicado: (2023)

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
por: Liu, Ya-Fei, et al.
Publicado: (2023)

Wuwei Qingzhuo San Ameliorates Hyperlipidemia in Mice Fed With HFD by Regulating Metabolomics and Intestinal Flora Composition
por: Ge, Shasha, et al.
Publicado: (2022)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

Berberine Reduces Lipid Accumulation by Promoting Fatty Acid Oxidation in Renal Tubular Epithelial Cells of the Diabetic Kidney
por: Rong, Qingfeng, et al.
Publicado: (2022)

Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress
por: Cui, Hong-Xin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5rm0i19t9bitp1oq63e2r0j2pu